Stock Traders Purchase Large Volume of Call Options on Walgreens Boots Alliance (WBA)

Walgreens Boots Alliance Inc (NASDAQ:WBA) was the recipient of some unusual options trading activity on Friday. Stock investors acquired 35,994 call options on the company. This is an increase of 833% compared to the average daily volume of 3,856 call options.

WBA has been the subject of a number of analyst reports. Pivotal Research reduced their price objective on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a report on Tuesday, October 24th. Loop Capital initiated coverage on shares of Walgreens Boots Alliance in a report on Thursday, August 24th. They set a “buy” rating and a $95.00 price objective for the company. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus target price of $86.47.

Walgreens Boots Alliance (NASDAQ WBA) opened at $70.18 on Wednesday. Walgreens Boots Alliance has a 1-year low of $63.82 and a 1-year high of $88.00. The stock has a market cap of $70,760.91, a PE ratio of 14.01, a P/E/G ratio of 1.27 and a beta of 1.22. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same period last year, the firm posted $1.07 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. equities analysts predict that Walgreens Boots Alliance will post 5.55 earnings per share for the current fiscal year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s leadership believes its stock is undervalued.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

In related news, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in WBA. Hudock Capital Group LLC increased its position in Walgreens Boots Alliance by 0.5% in the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares in the last quarter. Modera Wealth Management LLC grew its position in shares of Walgreens Boots Alliance by 0.4% during the 1st quarter. Modera Wealth Management LLC now owns 2,451 shares of the pharmacy operator’s stock worth $204,000 after buying an additional 9 shares during the period. Flagship Harbor Advisors LLC grew its position in shares of Walgreens Boots Alliance by 0.5% during the 1st quarter. Flagship Harbor Advisors LLC now owns 3,027 shares of the pharmacy operator’s stock worth $243,000 after buying an additional 16 shares during the period. Sowell Financial Services LLC grew its position in shares of Walgreens Boots Alliance by 0.6% during the 1st quarter. Sowell Financial Services LLC now owns 2,703 shares of the pharmacy operator’s stock worth $218,000 after buying an additional 17 shares during the period. Finally, WealthTrust Arizona LLC grew its position in shares of Walgreens Boots Alliance by 0.4% during the 2nd quarter. WealthTrust Arizona LLC now owns 5,264 shares of the pharmacy operator’s stock worth $412,000 after buying an additional 21 shares during the period. 60.24% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This article was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://stocknewstimes.com/2017/12/06/stock-traders-purchase-large-volume-of-call-options-on-walgreens-boots-alliance-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply